Consensus $1.92. Raises FY24 revenue view $980M-$990M from $975M-$985M, consensus $981.07M. The company said, “For the fiscal year ending January 31, 2024, management expects revenue of $980 million to $990 million. Its outlook for net income is between $19 million and $24 million, resulting in net income of $0.21 to $0.27 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $171 million and $179 million, resulting in non-GAAP net income per diluted share of $1.97 to $2.06 (based on an estimated 87 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $338 million to $348 million.”
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HQY:
- HealthEquity Reports Second Quarter Ended July 31, 2023 Financial Results
- Options Volatility and Implied Earnings Moves Today, September 05, 2023
- Options Volatility and Implied Earnings Moves This Week, September 05 – September 08, 2023
- Healthequity Inc (HQY) Q2 Earnings Cheat Sheet
- HealthEquity Announces Inaugural “HSA Week” to Increase Consumer Education and Engagement